These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17059639)

  • 1. Extended surveillance of gonorrhoea in Scotland 2003.
    Young H; McElhinney J; Palmer HM;
    Int J STD AIDS; 2006 Oct; 17(10):687-92. PubMed ID: 17059639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.
    Town K; Obi C; Quaye N; Chisholm S; Hughes G;
    Sex Transm Infect; 2017 Feb; 93(1):39-45. PubMed ID: 27382010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is new with antibiotic-resistant gonorrhoea in Newcastle, England?
    Elawad BB; Narayanan M; Pattman RS; Sankar KN; Freeman R
    Int J STD AIDS; 2002 Dec; 13(12):805-8. PubMed ID: 12537730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.
    Fenton KA; Ison C; Johnson AP; Rudd E; Soltani M; Martin I; Nichols T; Livermore DM;
    Lancet; 2003 May; 361(9372):1867-9. PubMed ID: 12788575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men.
    Palmer HM; Young H
    Int J STD AIDS; 2006 Apr; 17(4):254-6. PubMed ID: 16595048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin.
    Hopkins S; Coleman C; Kelleher M; Keating S; Clarke S; O'Connell B; Mulcahy F; Bergin C
    Ir Med J; 2005; 98(7):208-9. PubMed ID: 16185017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006.
    Delpech V; Martin IM; Hughes G; Nichols T; James L; Ison CA;
    Sex Transm Infect; 2009 Sep; 85(5):317-21. PubMed ID: 19383598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonorrhoea in London: usefulness of first line therapies.
    Ison CA; Martin IM;
    Sex Transm Infect; 2002 Apr; 78(2):106-9. PubMed ID: 12081169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance for first-line treatment of anogenital gonorrhoea infection.
    Tyson M
    Br J Nurs; 2005 Jun 23-Jul 13; 14(12):646-8, 650-2. PubMed ID: 16010215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ciprofloxacin resistance in gonococci isolated in Scotland.
    Forsyth A; Moyes A; Young H
    Lancet; 2000 Dec; 356(9246):1984-5. PubMed ID: 11130531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales.
    Hughes G; Nichols T; Ison CA
    Sex Transm Infect; 2011 Oct; 87(6):526-31. PubMed ID: 21917698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
    García S; Casco R; Perazzi B; De Mier C; Vay C; Famiglietti A
    Medicina (B Aires); 2008; 68(5):358-62. PubMed ID: 18977704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?
    Town K; Lowndes CM; Hughes G; Obi C; Chisholm S; Ison CA;
    Sex Transm Dis; 2015 Jan; 42(1):37-42. PubMed ID: 25504299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
    Coughlan EP; Franklin RA
    N Z Med J; 1996 Mar; 109(1017):82. PubMed ID: 8606827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
    Berglund T; Colucci B; Lund B; Qvarnström I; Sandström E
    Lakartidningen; 2004 Jul; 101(28-29):2332-5. PubMed ID: 15291311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8.
    Koedijk FD; van Veen MG; de Neeling AJ; Linde GB; van der Sande MA
    Sex Transm Infect; 2010 Feb; 86(1):41-5. PubMed ID: 19703843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis.
    Palmer HM; Young H; Martin IM; Ison CA; Spratt BG
    Sex Transm Infect; 2005 Oct; 81(5):403-7. PubMed ID: 16199740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RE: Ciprofloxacin resistance in Great Yarmouth and Waveney district.
    Harry TC
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):216-7. PubMed ID: 16441638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.